Literature DB >> 7632951

Human immature thymocytes as target cells of the leukemogenic activity of human T-cell leukemia virus type I.

V Maguer-Satta1, L Gazzolo, M D Dodon.   

Abstract

The risk of developing adult T-cell leukemia (ATL) associated with neonatal infection by human T-cell leukemia virus type I (HTLV-I) suggests that early events triggered by HTLV-I might be of crucial importance in initiating the multistep lymphoproliferative process leading several decades later to the development of leukemic disease. Thus, infection of thymocytes early in life might be directly correlated with the development of ATL. In the present study, we show that in vitro infection of mature (CD2+CD3+) or immature (CD2+CD3-) thymocytes resulted in the exogenous interleukin (IL)-2-dependent proliferation of HTLV-I-positive thymocytes, most of them displaying a CD2+CD3-CD4+ phenotype and expressing the CD25 molecule, the alpha chain of the IL-2 receptor. Furthermore, the CD80 and CD54 antigens, normally expressed by thymic stromal cells, were detected on these transformed thymocytes, indicating that HTLV-I infection may disturb the cooperation between thymocytes and their thymic environment. These HTLV-I-positive thymocytes were producing significant amounts of IL-6, which was found to be implicated in their proliferation and in the expression of CD25, as demonstrated by blocking experiments using a monoclonal antibody to IL-6. The present study suggests that immature thymocytes may provide an environment favorable to the unfolding of events leading to leukemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632951

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice.

Authors:  Saifur Rahman; Sharrón L Manuel; Zafar K Khan; Brian Wigdahl; Edward Acheampong; Frederic Tangy; Pooja Jain
Journal:  J Immunol       Date:  2010-04-09       Impact factor: 5.422

2.  Human T-cell leukemia virus type 1 Tax protein down-regulates pre-T-cell receptor alpha gene transcription in human immature thymocytes.

Authors:  Mélanie Wencker; Céline Sausse; David Derse; Louis Gazzolo; Madeleine Duc Dodon
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

3.  Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection.

Authors:  Saifur Rahman; Zafar K Khan; Brian Wigdahl; Stephen R Jennings; Frederic Tangy; Pooja Jain
Journal:  J Immunol       Date:  2010-11-29       Impact factor: 5.422

Review 4.  T helper cell activation and human retroviral pathogenesis.

Authors:  K F Copeland; J L Heeney
Journal:  Microbiol Rev       Date:  1996-12

5.  Human T-cell leukemia virus infection of human hematopoietic progenitor cells: maintenance of virus infection during differentiation in vitro and in vivo.

Authors:  G Feuer; J K Fraser; J A Zack; F Lee; R Feuer; I S Chen
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Case Report: Orbital Tumor Revealing Adult T-Cell Leukemia/Lymphoma Associated with Human T-Cell Lymphotropic Virus Type-1.

Authors:  Selim Farès; Rabih Hage; Jean Pegliasco; Samy Chraibi; Harold Merle
Journal:  Am J Trop Med Hyg       Date:  2018-06-28       Impact factor: 2.345

7.  HTLV-1 propels thymic human T cell development in "human immune system" Rag2⁻/⁻ gamma c⁻/⁻ mice.

Authors:  Julien Villaudy; Mélanie Wencker; Nicolas Gadot; Nicolas A Gillet; Jean-Yves Scoazec; Louis Gazzolo; Markus G Manz; Charles R M Bangham; Madeleine Duc Dodon
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

8.  Zika virus targets the human thymic epithelium.

Authors:  Carolina V Messias; Guilherme Loss-Morais; Joseane Biso de Carvalho; Mariela N González; Daniela P Cunha; Zilton Vasconcelos; Luis W P Arge; Désio A Farias-de-Oliveira; Alexandra L Gerber; Elyzabeth A Portari; Nilma Ferreira; Lidiane M S Raphael; Myrna C Bonaldo; Ingo Riederer; Maria E Lopes Moreira; Vinicius Cotta-de-Almeida; Ana T R Vasconcelos; Daniella A Mendes-da-Cruz; Wilson Savino
Journal:  Sci Rep       Date:  2020-01-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.